K.M. Boberg

753 total citations
17 papers, 522 citations indexed

About

K.M. Boberg is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, K.M. Boberg has authored 17 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in K.M. Boberg's work include Liver Diseases and Immunity (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Gallbladder and Bile Duct Disorders (4 papers). K.M. Boberg is often cited by papers focused on Liver Diseases and Immunity (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Gallbladder and Bile Duct Disorders (4 papers). K.M. Boberg collaborates with scholars based in Norway, Sweden and United States. K.M. Boberg's co-authors include Ingemar Björkhem, Kurt Einarsson, E. Schrumpf, Albert Parés, Ulrika Broomé, Roger W. Chapman, Giorgia Della Rocca, F. Rosina, Thore Egeland and S. Saarinen and has published in prestigious journals such as Hepatology, Journal of Hepatology and Journal of Lipid Research.

In The Last Decade

K.M. Boberg

17 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.M. Boberg Norway 7 431 340 241 106 78 17 522
Junko Hirohara Japan 10 303 0.7× 276 0.8× 259 1.1× 52 0.5× 84 1.1× 26 456
Enrico O. Souto United States 6 177 0.4× 146 0.4× 135 0.6× 67 0.6× 42 0.5× 12 305
Katsushi Amano Japan 9 286 0.7× 252 0.7× 110 0.5× 30 0.3× 53 0.7× 12 423
Chisa Kondo Japan 15 289 0.7× 336 1.0× 69 0.3× 40 0.4× 38 0.5× 45 487
Kazuhiro Atsukawa Japan 10 188 0.4× 124 0.4× 135 0.6× 121 1.1× 18 0.2× 26 378
Andrzej Habior Poland 11 164 0.4× 205 0.6× 102 0.4× 17 0.2× 37 0.5× 34 361
Petra Klöters-Plachky Germany 8 439 1.0× 234 0.7× 384 1.6× 313 3.0× 21 0.3× 9 626
D. Tsantoulas United Kingdom 8 160 0.4× 148 0.4× 105 0.4× 42 0.4× 74 0.9× 9 347
Bart J. Verwer Netherlands 7 345 0.8× 416 1.2× 141 0.6× 27 0.3× 33 0.4× 9 533
K. Patsiaoura Greece 11 108 0.3× 135 0.4× 131 0.5× 29 0.3× 60 0.8× 21 358

Countries citing papers authored by K.M. Boberg

Since Specialization
Citations

This map shows the geographic impact of K.M. Boberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.M. Boberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.M. Boberg more than expected).

Fields of papers citing papers by K.M. Boberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.M. Boberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.M. Boberg. The network helps show where K.M. Boberg may publish in the future.

Co-authorship network of co-authors of K.M. Boberg

This figure shows the co-authorship network connecting the top 25 collaborators of K.M. Boberg. A scholar is included among the top collaborators of K.M. Boberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.M. Boberg. K.M. Boberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nielsen, Morten, Douglas Thorburn, D.J. Leeming, et al.. (2016). Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients. Journal of Hepatology. 64(2). S199–S199. 2 indexed citations
2.
Goeppert, Benjamin, Trine Folseraas, Stéphanie Roessler, et al.. (2016). Novel Therapeutic Targets for Primary Sclerosing Cholangitis-Associated Biliary Tract Cancer Identified by Tissue Sequencing. Journal of Hepatology. 64(2). S225–S225. 1 indexed citations
3.
Åberg, Fredrik, Arno Nordin, ­Eero Pukkala, et al.. (2016). Decreasing Incidence of Cancer after Liver Transplantation - A Nordic Population-Based Study. Journal of Hepatology. 64(2). S216–S217. 1 indexed citations
4.
Boberg, K.M., et al.. (2013). Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid. Alimentary Pharmacology & Therapeutics. 38(7). 794–803. 17 indexed citations
5.
Hov, Johannes R., Vasilis Kosmoliaptsis, Marita Olsson, et al.. (2011). 22 ELECTROSTATIC MODIFICATIONS OF THE HLA-DR P9 PEPTIDE-BINDING POCKET AND SUSCEPTIBILITY TO PRIMARY SCLEROSING CHOLANGITIS. Journal of Hepatology. 54. S10–S11. 5 indexed citations
6.
Boberg, K.M., AW Lohse, Elke Hennes, et al.. (2009). ASSESSMENT OF 479 PATIENTS WITH AUTOIMMUNE LIVER DISEASES ACCORDING TO THE IAIHG SCORING SYSTEM FOR AUTOIMMUNE HEPATITIS DOES NOT SUPPORT THE CONTENTION OF OVERLAP SYNDROMES AS SEPARATE DIAGNOSTIC ENTITIES. Hepatology. 50. 6 indexed citations
8.
Parés, Albert, E. L. Krawitt, Gilda Porta, et al.. (2006). Simplified Diagnostic Criteria for Autoimmune Hepatitis. Zeitschrift für Gastroenterologie. 44(1). 14 indexed citations
9.
Olsson, Rolf, K.M. Boberg, Ove B. Schaffalitzky de Muckadell, et al.. (2005). High-dose ursodeoxycholic acid in primary sclerosing cholangitis:. 1464–1472. 7 indexed citations
10.
Olsson, Rolf, K.M. Boberg, Stefan Lindgren, et al.. (2004). 551 Five-year treatment with high-dose UDCA in PSC. Journal of Hepatology. 40. 161–162. 3 indexed citations
11.
Boberg, K.M., Anne Spurkland, Giorgia Della Rocca, et al.. (2001). The HLA-DR3,DQ2 Heterozygous Genotype is Associated with an Accelerated Progression of Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology. 36(8). 886–890. 44 indexed citations
12.
Boberg, K.M., S.A. Mitchell, Ulrika Broomé, et al.. (2000). Natural history of primary sclerosing cholangitis. A longterm follow-up study of 394 european primary sclerosing cholangitis patients. Journal of Hepatology. 32. 32–32. 6 indexed citations
13.
Saarinen, S., K.M. Boberg, Anne Spurkland, et al.. (1998). HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups.. Hepatology. 28. 1 indexed citations
14.
Boberg, K.M., Giorgia Della Rocca, Anne Spurkland, et al.. (1998). Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model.. Hepatology. 28. 1 indexed citations
15.
Boberg, K.M.. (1998). Incidence and Prevalence of Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, and Autoimmune Hepatitis in a Norwegian Population. Scandinavian Journal of Gastroenterology. 33(1). 99–103. 362 indexed citations
16.
Boberg, K.M. & E. Schrumpf. (1997). [Treatment of cholestatic liver diseases with ursodeoxycholic acid].. PubMed. 117(23). 3370–3. 1 indexed citations
17.
Boberg, K.M., Kurt Einarsson, & Ingemar Björkhem. (1990). Apparent lack of conversion of sitosterol into C24-bile acids in humans.. Journal of Lipid Research. 31(6). 1083–1088. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026